FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Terzah Horton

Research Profile

Disorders

Concepts & Ideas

Living Beings

Infants

Chemicals & Drugs

Anatomy

Tumor Cell Line

Procedures

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Jodi A Muscal; Joel M Reid; Patrick A Thompson; Brenda J Weigel; Igor Espinoza-Delgado; Terzah M Horton; Ashish Ingle; Renee M McGovern; Charlotte H Ahern; Matthew M Ames; Susan M Blaney
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).
D J Morrison; Naomi P Moskowitz; Elizabeth A Raetz; David Teachey; Ilana Belitskaya-Levy; T Bhatla; Deepa Bhojwani; G Condos; N Germino; L M Greenberger; Stephan A Grupp; Laura E Hogan; I D Horak; Terzah M Horton; L Lee; William L Carroll
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models.
Conrad R Cruz; Ulrike Gerdemann; Helen E Heslop; Terzah M Horton; Stephanie Ku; Ann M Leen; Cliona M Rooney; Jessica A Shafer; Andrea Sheehan; Benjamin Tzou; Anas Younes; Amanda Copeland; Catherine M Bollard
Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Terzah Horton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jodi A Muscal; Joel M Reid; Patrick A Thompson; Brenda J Weigel; Igor Espinoza-Delgado; Terzah M Horton; Ashish Ingle; Renee M McGovern; Charlotte H Ahern; Matthew M Ames; Susan M Blaney
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).
Pediatric blood & cancer 2013;60(3):390-5.
2012: D J Morrison; Naomi P Moskowitz; Elizabeth A Raetz; David Teachey; Ilana Belitskaya-Levy; T Bhatla; Deepa Bhojwani; G Condos; N Germino; L M Greenberger; Stephan A Grupp; Laura E Hogan; I D Horak; Terzah M Horton; L Lee; William L Carroll
Endogenous knockdown of survivin improves chemotherapeutic response in ALL models.
Leukemia 2012;26(2):271-9.
2011: Conrad R Cruz; Ulrike Gerdemann; Helen E Heslop; Terzah M Horton; Stephanie Ku; Ann M Leen; Cliona M Rooney; Jessica A Shafer; Andrea Sheehan; Benjamin Tzou; Anas Younes; Amanda Copeland; Catherine M Bollard
Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(22):7058-66.
2011: Terzah M Horton; Stacey L Berg
Educational paper. The development of new therapies for pediatric oncology.
European journal of pediatrics 2011;170(5):555-9.
2010: Terzah M Horton; Richard Sposto; Patrick Brown; Charles Patrick Reynolds; Stephen P Hunger; Naomi J Winick; Elizabeth A Raetz; William L Carroll; Robert J Arceci; Michael J Borowitz; Paul S Gaynon; Lia Gore; Sima Jeha; Barry J Maurer; Stuart E Siegel; Andrea Biondi; Pamela R Kearns; Aru Narendran; Lewis B Silverman; Malcolm A Smith; C Michel Zwaan; James A Whitlock
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conference.
Pediatric blood & cancer 2010;54(7):872-8.
2009: Dipanjan Basu; Nenggang Zhang; Anil K Panigrahi; Terzah M Horton; Debananda Pati
Development and validation of a fluorogenic assay to measure separase enzyme activity.
Analytical biochemistry 2009;392(2):133-8.
2009: Terzah M Horton; Gaye Jenkins; Debananda Pati; Linna Zhang; M Eileen Dolan; Albert Ribes-Zamora; Alison A Bertuch; Susan M Blaney; Shannon L Delaney; Madhuri Hegde; Stacey L Berg
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.
Molecular cancer therapeutics 2009;8(8):2232-42.
2008: Terzah M Horton; Matthew M Ames; Joel M Reid; Mark Krailo; Thomas Pendergrass; Revonda B Mosher; Gregory H Reaman; Nita L Seibel
A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study.
Pediatric blood & cancer 2008;50(4):788-92.
2007: Terzah M Horton; Patrick A Thompson; Stacey L Berg; Peter Charles Adamson; Ashish Ingle; M Eileen Dolan; Shannon M Delaney; Madhuri Hedge; Heidi L Weiss; Meng-Fen Wu; Susan M Blaney
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4922-8.
2007: Terzah M Horton; Debananda Pati; Sharon E Plon; Patrick A Thompson; Lisa R Bomgaars; Peter Charles Adamson; Ashish Ingle; John Wright; Adam H Brockman; Martin Paton; Susan M Blaney
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(5):1516-22.
2006: Dong-Joon Min; Naomi P Moskowitz; Carrie Brownstein; Hokyung Lee; Terzah M Horton; William L Carroll
Diverse pathways mediate chemotherapy-induced cell death in acute lymphoblastic leukemia cell lines.
Apoptosis : an international journal on programmed cell death 2006;11(11):1977-86.
2006: Terzah M Horton; Anu Gannavarapu; Susan M Blaney; David Z D'Argenio; Sharon E Plon; Stacey L Berg
Bortezomib interactions with chemotherapy agents in acute leukemia in vitro.
Cancer chemotherapy and pharmacology 2006;58(1):13-23.
2005: Terzah M Horton; Susan M Blaney; Anne-Marie Langevin; John Kuhn; Barton A. Kamen; Stacey L Berg; Mark Bernstein; Steven D Weitman
Phase I trial and pharmacokinetic study of raltitrexed in children with recurrent or refractory leukemia: a pediatric oncology group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(5):1884-9.
2004: Susan M Blaney; Mark Bernstein; Kathleen Neville; Jill P Ginsberg; Brenda Joyce Kitchen; Terzah M Horton; Stacey L Berg; Mark Krailo; Peter Charles Adamson
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4804-9.
2004: Mary Nell Suell; Terzah M Horton; Megan K Dishop; Donald H Mahoney; Oluyinka O Olutoye; Brigitta U Mueller
Outcomes for children with gallbladder abnormalities and sickle cell disease.
The Journal of pediatrics 2004;145(5):617-21.
2003: Terzah M Horton; Jeffrey D Stone; Donald Yee; ZoAnn E Dreyer; Joel L Moake; Donald H Mahoney
Case series of thrombotic thrombocytopenic purpura in children and adolescents.
Journal of pediatric hematology/oncology 2003;25(4):336-9.